EUVIMEDDescoperă EUVIMED
VergleichsstudieOpen access · CC BY-NC-ND 4.0

Comparative analysis of endometrial, vaginal, and gut microbiota in patients with and without adenomyosis

Marta Valdés-Bango iD, Meritxell Gracia, Elisa Rubio, Andrea Vergara, Climent Casals-Pascual, Cristina Ros, Mariona Rius, Maria Ángeles Martínez-Zamora, Eduard Mension, Lara Quintas, Francisco Carmona iD

Acta Obstetricia et Gynecologica Scandinavica · 2024-07 · 103 (7) · 1271-1282

DOI: 10.1111/aogs.14847 ↗

At a glance

Vergleichsstudie in Acta Obstetricia et Gynecologica Scandinavica, published online on 2024-04-25. Written by Marta Valdés-Bango and 10 co-authors. Institution: Endometriosis Unit, Gynecology Department, Institute Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clinic of Barcelona, Universi…. Major MEDLINE topics: Adenomyosis, Gastrointestinal Microbiome, Vagina, Endometrium. Cited 23 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Introduction

Alterations in microbiota composition have been implicated in a variety of human diseases. Patients with adenomyosis present immune dysregulation leading to a persistent chronic inflammatory response. In this context, the hypothesis that alterations in the microbiota may be involved in the pathogenesis of adenomyosis, by affecting the epigenetic, immunologic, and biochemical functions of the host, has recently been postulated. The aim of the present study was to compare the microbiota composition in the vagina, endometrium, and gut of individuals with and without adenomyosis. Material and Methods Cross‐sectional study including 38 adenomyosis patients and 46 controls, performed between September 2021 and October 2022 in a university hospital‐based research center. The diagnosis of adenomyosis was based on sonographic criteria. Fecal, vaginal, and endometrial samples were collected. Study of the microbiota using 16S rRNA gene sequencing.

Results

Patients with adenomyosis exhibited a significant reduction in the gut microbial alpha diversity compared with healthy controls (Chao1 p = 0.012, Fisher p = 0.005, Observed species p = 0.005). Beta‐diversity analysis showed significant differences in the compositions of both gut and vaginal microbiota between adenomyosis patients and the control group (Adonis p ‐value = 0.001; R 2 = 0.03 and Adonis p ‐value = 0.034; R 2 = 0.04 respectively). Specific bacterial taxa were found to be either overrepresented (Rhodospirillales, Ruminococcus gauvreauii group, Ruminococcaceae, and Actinomyces) or underrepresented in the gut and endometrial microbiota of adenomyosis patients compared with controls. Distinct microbiota profiles were identified among patients with internal and external adenomyosis phenotypes.

Conclusions

The study revealed reduced gut microbiota diversity in adenomyosis patients, accompanied by distinct compositions in gut and vaginal microbiota compared with controls. Overrepresented or underrepresented bacterial taxa were noted in the gut and endometrial microbiota of adenomyosis patients, with variations in microbiota profiles among those with internal and external adenomyosis phenotypes. These findings suggest a potential association between microbiota and adenomyosis, indicating the need for further research to comprehensively understand the implications of these differences.

Subjects

MeSH terms (MEDLINE)

AdenomyosisGastrointestinal MicrobiomeVaginaEndometriumHumansFemaleCross-Sectional StudiesAdultMiddle AgedCase-Control StudiesRNA, Ribosomal, 16S

Author keywords

16S rRNA sequencingadenomyosisendometrial microbiotagut microbiotavaginal microbiota

Substances

RNA, Ribosomal, 16S

Authors and institutions

  • Endometriosis Unit, Gynecology Department, Institute Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Department of Clinical Microbiology, Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
  • CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto Salud Carlos III, Madrid, Spain.

ORCID profiles: Marta Valdés-Bango, Francisco Carmona

Cite

APA

Valdés-Bango, M., Gracia, M., Rubio, E., Vergara, A., Casals-Pascual, C., Ros, C., Rius, M., Martínez-Zamora, M. Á., Mension, E., Quintas, L., & Carmona, F. (2024). Comparative analysis of endometrial, vaginal, and gut microbiota in patients with and without adenomyosis. Acta Obstetricia et Gynecologica Scandinavica, 103(7), 1271-1282. https://doi.org/10.1111/aogs.14847

Vancouver

Valdés-Bango M, Gracia M, Rubio E, Vergara A, Casals-Pascual C, Ros C, et al. Comparative analysis of endometrial, vaginal, and gut microbiota in patients with and without adenomyosis. Acta Obstetricia et Gynecologica Scandinavica. 2024;103(7):1271-1282. doi:10.1111/aogs.14847

BibTeX
@article{ValdsBango2024,
  author = {Valdés-Bango, Marta and Gracia, Meritxell and Rubio, Elisa and Vergara, Andrea and Casals-Pascual, Climent and Ros, Cristina and Rius, Mariona and Martínez-Zamora, Maria Ángeles and Mension, Eduard and Quintas, Lara and Carmona, Francisco},
  title = {Comparative analysis of endometrial, vaginal, and gut microbiota in patients with and without adenomyosis},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  volume = {103},
  number = {7},
  pages = {1271--1282},
  doi = {10.1111/aogs.14847}
}
Start for free →